Cardlytics, Inc. (CDLX) Q2 2026 Earnings Call Transcript
Cardlytics, Inc. (CDLX) Q2 2026 Earnings Call Transcript
Seeking Alpha8/6/2026Neutral
CDLX
Cardlytics IncNASDAQCOMMUNICATION SERVICESADVERTISING AGENCIES
Key Statistics
Market Cap
$23.85M
P/E Ratio
—
EPS
$-19.83
Beta
0.67
52W High
$32.80
52W Low
$3.49
50-Day MA
$4.44
200-Day MA
$8.86
Dividend Yield
—
Profit Margin
-52.80%
Forward P/E
36.50
PEG Ratio
—
About Cardlytics Inc
Cardlytics, Inc. operates an advertising platform within financial institutions' digital channels including online, mobile, email, and various real-time notifications in the United States and the United Kingdom. The company is headquartered in Atlanta, Georgia.
Fundamentals
| Revenue (TTM) | $190.00M |
| Gross Profit (TTM) | $92.86M |
| EBITDA | $-13.97M |
| Operating Margin | -14.70% |
| Return on Equity | -513.00% |
| Return on Assets | -7.37% |
| Revenue/Share (TTM) | $34.49 |
| Book Value | $-2.76 |
| Price-to-Book | 2.15 |
| Price-to-Sales (TTM) | 0.13 |
| EV/Revenue | 0.983 |
| EV/EBITDA | -7.69 |
| Quarterly Earnings Growth (YoY) | -56.70% |
| Quarterly Revenue Growth (YoY) | -36.50% |
| Shares Outstanding | $5.89M |
| Float | $5.19M |
| % Insiders | 4.54% |
| % Institutions | 29.24% |
Historical Volatility
HV 10-Day
102.55%
HV 20-Day
86.06%
HV 30-Day
78.41%
HV 60-Day
75.92%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($6.00 target)
3
Hold1
Strong SellLatest News
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) announced that on Aug. 3, 2026, Cardlytics granted an aggregate of 50,000 restricted stock units of Cardlytics to its newly appointed Chief Legal Officer, Chris Cheng. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”). The restricted stock units shall v.
Business Wire8/3/2026Neutral
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on July 29, 2026, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 10,320 restricted stock units of Cardlytics to 10 newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”). For a.
Business Wire7/31/2026Neutral
Cardlytics Appoints Chris Cheng as Chief Legal Officer
ATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced the appointment of Chris Cheng as Chief Legal Officer, effective August 3, 2026. Cheng will serve on the Leadership Team and oversee Cardlytics Legal and Compliance organization. Cheng brings more than 20 years of legal leadership experience at high-growth technology companies, with deep expertise supporting public companies and partnering with executive teams during periods of transformation. With senior legal experience.
Business Wire7/29/2026Neutral
Cardlytics to Report Second Quarter 2026 Results on August 5
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that its financial results for the second quarter ending June 30, 2026 will be released on August 5, 2026, after market close. Conference Call Details: When: August 5, 2026 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access the live audio webcast on the Cardlytics Investor Relations website at ir.cardlytics.com, or by registering at this link. Following the call, a replay will be available on the.
Business Wire7/21/2026Neutral
Cardlytics, Inc. (CDLX) Q1 2026 Earnings Call Transcript
Cardlytics, Inc. (CDLX) Q1 2026 Earnings Call Transcript
Seeking Alpha5/8/2026Neutral
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on April 29, 2026, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 272,000 restricted stock units of Cardlytics to six newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”). Fo.
Business Wire5/1/2026Neutral
CORRECTING and REPLACING Cardlytics Announces Timing of Its First Quarter 2026 Earnings Release
ATLANTA--(BUSINESS WIRE)--Q126 earnings release.
Business Wire5/1/2026Neutral
Cardlytics Announces Timing of Its First Quarter 2026 Earnings Release
ATLANTA--(BUSINESS WIRE)--Q126 earnings release.
Business Wire4/27/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CDLX and any ticker you trade — then tracks every position and per-strategy win rate.
More COMMUNICATION SERVICES Stocks
Data last updated: 8/18/2026